The alternative value of thyroid stimulating hormone instead of thyroglobulin in differentiation of follicular thyroid neoplasm in Hashimoto’s thyroiditis
Distinguishing FTC from FTA remains a challenge for ultrasonography and FNA. Serum TG should be measured as a risk factor of FTC. However, in HT patients, serum TSH levels can serve as a more reliable indicator for differentiating FTC from FTA preoperatively.
Authors
- Zhuoran Liu (ORCID: https://orcid.org/0000-0002-3953-0637)
- Jinyue Liu (ORCID: https://orcid.org/0009-0009-4725-3797)
- Hanxing Sun (ORCID: https://orcid.org/0000-0001-8502-6397)
- Lingxie Chen
- Qinyu Li (ORCID: https://orcid.org/0009-0007-4133-222X)
- Rui Li (ORCID: https://orcid.org/0000-0002-2379-5219)
- Jie Kuang (ORCID: https://orcid.org/0000-0001-7336-732X)
- Weihua Qiu (ORCID: https://orcid.org/0000-0002-9636-2000)
- Jiqi Yan (ORCID: https://orcid.org/0009-0009-0868-0059)
- Ling Zhan (ORCID: https://orcid.org/0000-0002-2186-8410)
- Ri Hong
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.3389/fonc.2024.1395202
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China